ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy of Single-agent CC-5013 in Subjects With Relapsed and Refractory Multiple Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00065351
Recruitment Status : Completed
First Posted : July 23, 2003
Last Update Posted : November 23, 2016
Sponsor:
Information provided by (Responsible Party):
Celgene Corporation